Back

Circulating dipeptidyl peptidase 3: new hope for a specific treatment to improve prognosis in cardiogenic shock?

European Heart Journal

26 August 2023
Organised by: Logo
Read full article
ESC Journals CORONARY ARTERY DISEASE, ACUTE CORONARY SYNDROMES, ACUTE CARDIAC CARE Acute Cardiac Care Acute Coronary Syndromes

Contributors

Janine Pöss
Janine Pöss

Author

Petra Büttner
Petra Büttner

Author

Heart Center of Leipzig Leipzig , Germany

Holger Thiele
Holger Thiele

Author

Heart Center Leipzig at University of Leipzig Leipzig , Germany

You may be interested in
thumbnail
Congress Presentation
The source of liberation of dipeptidyl peptidase 3 (DPP3), a newly emerged cardiac biomarker, in pathological situations
20 May 2023
thumbnail
Congress Presentation
All patients should be considered for mechanical circulatory support - discussion
1 September 2025
thumbnail
Congress Presentation
Circulating secretoneurin concentrations predict 90-day mortality in patients with cardiogenic shock
30 August 2024
thumbnail
Congress Presentation
Low-dose dobutamine infusion and single-dose tocilizumab in acute myocardial infarction patients with high risk of cardiogenic shock development - rationale and design of the DOBERMANN trial
24 March 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources